Cholera Due to Altered El Tor Strains of Vibrio Cholerae O1 in Bangladesh

Overview

Journal J Clin Microbiol

Specialty Microbiology

Date 2006 Sep 8

PMID 16957040

Citations 102

Authors

G Balakrish Nair

Firdausi Qadri

Jan Holmgren

Ann-Mari Svennerholm

Ashrafus Safa

Nurul A Bhuiyan

Q Shafi Ahmad

Shah M Faruque

A S G Faruque

Yoshifumi Takeda

David A Sack

Affiliations

Soon will be listed here.

Abstract

We determined the types of cholera toxin (CT) produced by a collection of 185 Vibrio cholerae O1 strains isolated in Bangladesh over the past 45 years. All of the El Tor strains of V. cholerae O1 isolated since 2001 produced CT of the classical biotype, while those isolated before 2001 produced CT of the El Tor biotype.

Citing Articles

An acute diarrheal disease outbreak in urban setting of Odisha, India.

Kerketta S, Rout U, Kshatri J, Kerketta A, Paikaray A, Dash A BMC Infect Dis. 2025; 25(1):283.

PMID: 40016643 PMC: 11866558. DOI: 10.1186/s12879-025-10683-2.

Variations in the Antivirulence Effects of Fatty Acids and Virstatin against Strains.

Lee D, Joo J, Choi H, Son S, Bae J, Kim D J Microbiol Biotechnol. 2024; 34(9):1757-1768.

PMID: 39187456 PMC: 11485679. DOI: 10.4014/jmb.2405.05002.

Cholera rages in Africa and the Middle East: A narrative review on challenges and solutions.

Ahmed A, Sijercic V, Akhtar M, Elbayomy A, Marouf M, Zeleke M Health Sci Rep. 2024; 7(5):e2013.

PMID: 38742091 PMC: 11089255. DOI: 10.1002/hsr2.2013.

, classification, pathogenesis, immune response, and trends in vaccine development.

Montero D, Vidal R, Velasco J, George S, Lucero Y, Gomez L Front Med (Lausanne). 2023; 10:1155751.

PMID: 37215733 PMC: 10196187. DOI: 10.3389/fmed.2023.1155751.

Sporadic type VI secretion in seventh pandemic .

Proutiere A, Drebes Dorr N, Bader L, Stutzmann S, Metzger L, Isaac S Microbiology (Reading). 2023; 169(5).

PMID: 37134007 PMC: 10268840. DOI: 10.1099/mic.0.001329.

References

Karaolis D, Lan R, REEVES P . The sixth and seventh cholera pandemics are due to independent clones separately derived from environmental, nontoxigenic, non-O1 Vibrio cholerae. J Bacteriol. 1995; 177(11):3191-8. PMC: 177010. DOI: 10.1128/jb.177.11.3191-3198.1995. View

Nair G, Faruque S, Bhuiyan N, Kamruzzaman M, Siddique A, Sack D . New variants of Vibrio cholerae O1 biotype El Tor with attributes of the classical biotype from hospitalized patients with acute diarrhea in Bangladesh. J Clin Microbiol. 2002; 40(9):3296-9. PMC: 130785. DOI: 10.1128/JCM.40.9.3296-3299.2002. View

Mitra R, Nandy R, Ramamurthy T, Bhattacharya S, Yamasaki S, Shimada T . Molecular characterisation of rough variants of Vibrio cholerae isolated from hospitalised patients with diarrhoea. J Med Microbiol. 2001; 50(3):268-276. DOI: 10.1099/0022-1317-50-3-268. View

Sack D, Sack R, Nair G, Siddique A . Cholera. Lancet. 2004; 363(9404):223-33. DOI: 10.1016/s0140-6736(03)15328-7. View

Qadri F, Raqib R, Ahmed F, Rahman T, Wenneras C, Das S . Increased levels of inflammatory mediators in children and adults infected with Vibrio cholerae O1 and O139. Clin Diagn Lab Immunol. 2002; 9(2):221-9. PMC: 119937. DOI: 10.1128/cdli.9.2.221-229.2002. View

Tamplin M, Jalali R, Ahmed M, Colwell R . Variation in epitopes of the B subunit of Vibrio cholerae non-O1 and Vibrio mimicus cholera toxins. Can J Microbiol. 1990; 36(6):409-13. DOI: 10.1139/m90-071. View

Finkelstein R, Burks M, Zupan A, Dallas W, Jacob C, Ludwig D . Epitopes of the cholera family of enterotoxins. Rev Infect Dis. 1987; 9(3):544-61. DOI: 10.1093/clinids/9.3.544. View

Olsvik O, Wahlberg J, Petterson B, Uhlen M, Popovic T, Wachsmuth I . Use of automated sequencing of polymerase chain reaction-generated amplicons to identify three types of cholera toxin subunit B in Vibrio cholerae O1 strains. J Clin Microbiol. 1993; 31(1):22-5. PMC: 262614. DOI: 10.1128/jcm.31.1.22-25.1993. View

Dziejman M, Balon E, Boyd D, Fraser C, Heidelberg J, Mekalanos J . Comparative genomic analysis of Vibrio cholerae: genes that correlate with cholera endemic and pandemic disease. Proc Natl Acad Sci U S A. 2002; 99(3):1556-61. PMC: 122229. DOI: 10.1073/pnas.042667999. View

10.

Marchlewicz B, Finkelstein R . Immunological differences among the cholera/coli family of enterotoxins. Diagn Microbiol Infect Dis. 1983; 1(2):129-38. DOI: 10.1016/0732-8893(83)90042-1. View

11.

Clemens J, Sack D, Harris J, Van Loon F, Chakraborty J, Ahmed F . Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up. Lancet. 1990; 335(8684):270-3. DOI: 10.1016/0140-6736(90)90080-o. View

12.

Iwanaga M, Yamamoto K, Higa N, Ichinose Y, Nakasone N, Tanabe M . Culture conditions for stimulating cholera toxin production by Vibrio cholerae O1 El Tor. Microbiol Immunol. 1986; 30(11):1075-83. DOI: 10.1111/j.1348-0421.1986.tb03037.x. View

13.

Kaper J, Bradford H, Roberts N, Falkow S . Molecular epidemiology of Vibrio cholerae in the U.S. Gulf Coast. J Clin Microbiol. 1982; 16(1):129-34. PMC: 272308. DOI: 10.1128/jcm.16.1.129-134.1982. View

14.

Svennerholm A, Wikstrom M, Lindblad M, Holmgren J . Monoclonal antibodies to Escherichia coli heat-labile enterotoxins: neutralising activity and differentiation of human and porcine LTs and cholera toxin. Med Biol. 1986; 64(1):23-30. View

15.

Ansaruzzaman M, Bhuiyan N, Nair B, Sack D, Lucas M, Deen J . Cholera in Mozambique, variant of Vibrio cholerae. Emerg Infect Dis. 2005; 10(11):2057-9. PMC: 3329043. DOI: 10.3201/eid1011.040682. View